BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9726012)

  • 1. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.
    Murray JM; O'Neill JP; Messier T; Rivers J; Walker VE; McGonagle B; Trombley L; Cowell LG; Kelsoe G; McBlane F; Finette BA
    J Immunol; 2006 Oct; 177(8):5393-404. PubMed ID: 17015725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.
    Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ
    Mol Cell Biol; 2001 Jan; 21(2):400-13. PubMed ID: 11134329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.
    Onozawa M; Aplan PD
    Genes Chromosomes Cancer; 2012 Jun; 51(6):525-35. PubMed ID: 22334400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
    Fenstermaker RA; Ciesielski MJ
    Curr Genomics; 2007 May; 8(3):163-70. PubMed ID: 18645600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origins of V(D)J recombination.
    Lewis SM; Wu GE
    Cell; 1997 Jan; 88(2):159-62. PubMed ID: 9008155
    [No Abstract]   [Full Text] [Related]  

  • 6. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells.
    Chen CL; Fuscoe JC; Liu Q; Relling MV
    Blood; 1996 Sep; 88(6):2210-8. PubMed ID: 8822941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
    Finette BA; Poseno T; Albertini RJ
    Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
    Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
    Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
    Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
    J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Messier TL; O'Neill JP; Finette BA
    Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
    Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
    Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.